TC BioPharm(TCBP)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TCBP TC BioPharm

退市 04-11 16:00:00 EDT

0.5000

+0.0000

0.00%

最高0.5000	最低0.5000	成交量0.00
今开0.5000	昨收0.5000	日振幅0.00%
总市值25.65万	流通市值25.64万	总股本51.30万
成交额0.00	换手率0.00%	流通股本51.28万
市净率0.10	ROE-577.04%	每股收益-78.81
52周最高523.20	52周最低0.5000	市盈率-0.01
股息0.00	股息收益率0.00	ROA-98.20%

北京优虎网络科技有限公司

{"stockData":{"symbol":"TCBP","market":"US","secType":"STK","nameCN":"TC BioPharm","latestPrice":0.5,"timestamp":1744401600000,"preClose":0.5,"halted":4,"volume":0,"delay":0,"floatShares":512800,"shares":512991,"eps":-78.8143,"marketStatus":"退市","change":0,"latestTime":"04-11 16:00:00 EDT","open":0.5,"high":0.5,"low":0.5,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-78.8143,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1744617600000},"marketStatusCode":0,"adr":0,"adrRate":4000,"listingDate":1644555600000,"exchange":"NASDAQ","adjPreClose":0.5,"volumeRatio":0},"requestUrl":"/m/hq/s/TCBP","defaultTab":"news","newsList":[{"id":"2518279853","title":"Tc Biopharm (Holdings) Plc盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518279853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518279853?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:32","pubTimestamp":1741613521,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时32分，Tc Biopharm  Plc股票出现异动，股价快速上涨5.04%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2012.65%、398.85%、56.02%，振幅较大的相关个股有Xencor, Inc.、Seer, Inc.、珐博进，振幅分别为99.13%、98.72%、98.49%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213201964035dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213201964035dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCBP"],"gpt_icon":0},{"id":"2517169332","title":"Tc Biopharm (Holdings) Plc盘中异动 早盘股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517169332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517169332?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:53","pubTimestamp":1741272797,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时53分，Tc Biopharm  Plc股票出现波动，股价急速拉升5.20%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.54%。其相关个股中，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Tonix Pharmaceuticals Holding Corp.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Aditxt, Inc.较为活跃，换手率分别为1363.95%、419.19%、66.09%，振幅较大的相关个股有Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为33.60%、31.58%、28.10%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306225318a2629677&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306225318a2629677&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2517529910","title":"Tc Biopharm (Holdings) Plc盘中异动 股价大跌5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517529910","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517529910?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185061,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，Tc Biopharm  Plc股票出现波动，股价大幅下挫5.67%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.00%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223101a260c6e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223101a260c6e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2516632592","title":"Tc Biopharm (Holdings) Plc盘中异动 股价大跌7.63%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516632592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516632592?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:36","pubTimestamp":1741012596,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时36分，Tc Biopharm  Plc股票出现异动，股价大幅下跌7.63%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为48.35%、32.75%、30.97%，振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Pliant Therapeutics, Inc.，振幅分别为21.22%、19.25%、16.68%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032236369637ad8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032236369637ad8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCBP"],"gpt_icon":0},{"id":"2514373597","title":"Tc Biopharm (Holdings) Plc盘中异动 早盘急速跳水6.45%报2.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514373597","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514373597?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:58","pubTimestamp":1740754716,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时58分，Tc Biopharm  Plc股票出现异动，股价大幅跳水6.45%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.13%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822583798968074&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822583798968074&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCBP"],"gpt_icon":0},{"id":"2514562938","title":"Tc Biopharm (Holdings) Plc盘中异动 早盘股价大跌5.38%报2.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514562938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514562938?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:45","pubTimestamp":1740581153,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时45分，Tc Biopharm  Plc股票出现异动，股价急速跳水5.38%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.46%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262245539893adc5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262245539893adc5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2514009028","title":"Tc Biopharm (Holdings) Plc盘中异动 股价大跌5.31%报2.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514009028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514009028?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:44","pubTimestamp":1740494647,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时44分，Tc Biopharm  Plc股票出现波动，股价快速跳水5.31%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为852.54%、616.97%、529.61%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Gt Biopharma, Inc.，振幅分别为100.27%、46.65%、33.50%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224407a2538a31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224407a2538a31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2513720976","title":"Tc Biopharm (Holdings) Plc盘中异动 股价大跌5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720976","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513720976?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:07","pubTimestamp":1740409652,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时07分，Tc Biopharm  Plc股票出现异动，股价大幅下跌5.80%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.64%。其相关个股中，Pepgen Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Telix Pharmaceutic涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为165.81%、72.11%、25.99%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、42.86%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230732962ea1d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230732962ea1d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2513215395","title":"Tc Biopharm (Holdings) Plc盘中异动 快速下跌5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513215395","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513215395?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:51","pubTimestamp":1740160284,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日01时51分，Tc Biopharm  Plc股票出现波动，股价快速下跌5.73%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Invivyd, Inc.、Osr Holdings, Inc.涨幅较大，Nkgen Biotech, Inc.、Aditxt, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为242.42%、239.90%、133.14%，振幅较大的相关个股有Osr Holdings, Inc.、Osr Holdings Inc C/Wts 09/02/2028 、Invivyd, Inc.，振幅分别为72.46%、57.50%、48.76%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222015125988e0a77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222015125988e0a77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2512854734","title":"Tc Biopharm (Holdings) Plc盘中异动 股价大跌5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512854734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512854734?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:31","pubTimestamp":1739975509,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时31分，Tc Biopharm  Plc股票出现波动，股价快速跳水5.49%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Osr Holdings, Inc.、Aditxt, Inc.、Citius Pharmaceuticals, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Chemomab Therapeutics Ltd较为活跃，换手率分别为207.93%、202.33%、65.61%，振幅较大的相关个股有Osr Holdings, Inc.、Azitra Inc、2Seventy Bio, Inc.，振幅分别为24.48%、11.29%、7.53%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223150a24bf978&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223150a24bf978&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCBP"],"gpt_icon":0},{"id":"2512165293","title":"Tc Biopharm (Holdings) Plc盘中异动 早盘大幅跳水5.12%报2.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165293","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512165293?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:33","pubTimestamp":1739889202,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时33分，Tc Biopharm  Plc股票出现波动，股价快速跳水5.12%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.08%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。利用 GD-T 的先天能力，该公司能够开发出一系列旨在对抗癌症和病毒感染的临床阶段细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223323a24aad30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223323a24aad30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2511852633","title":"Tc Biopharm (Holdings) Plc盘中异动 早盘快速跳水5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511852633","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511852633?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:38","pubTimestamp":1739457517,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时38分，Tc Biopharm  Plc股票出现波动，股价快速下挫5.26%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Edesa Biotech, Inc.、Moleculin Biotech, Inc.、Dominari Holdings Inc.涨幅较大，Tc Biopharm  Plc、Edesa Biotech, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1011.16%、930.29%、150.39%，振幅较大的相关个股有Moleculin Biotech, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Edesa Biotech, Inc.，振幅分别为56.19%、32.86%、29.56%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132238379621bdc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502132238379621bdc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCBP"],"gpt_icon":0},{"id":"2510806943","title":"Tc Biopharm (Holdings) Plc盘中异动 早盘股价大跌6.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510806943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510806943?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:31","pubTimestamp":1739284273,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时31分，Tc Biopharm  Plc股票出现波动，股价急速下挫6.31%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.92%。其相关个股中，Dominari Holdings Inc.、In8Bio, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.较为活跃，换手率分别为1878.94%、504.70%、170.12%，振幅较大的相关个股有Dominari Holdings Inc.、In8Bio, Inc.、Lipella Pharmaceuticals Inc.，振幅分别为18.18%、14.11%、8.85%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112231149881bcb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112231149881bcb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCBP"],"gpt_icon":0},{"id":"2510865643","title":"Tc Biopharm (Holdings) Plc盘中异动 早盘股价大涨11.66%报4.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510865643","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510865643?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:33","pubTimestamp":1739197987,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时33分，Tc Biopharm  Plc股票出现异动，股价快速拉升11.66%。截至发稿，该股报4.50美元/股，成交量8558股，换手率1.67%，振幅6.20%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.32%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223307abc9a57c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223307abc9a57c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139","OCEA"],"gpt_icon":0},{"id":"2509205821","title":"Tc Biopharm (Holdings) Plc盘中异动 急速下挫5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509205821","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509205821?lang=zh_cn&edition=full","pubTime":"2025-02-06 23:53","pubTimestamp":1738857206,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日23时53分，Tc Biopharm  Plc股票出现波动，股价大幅跳水5.53%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Equillium, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Azitra Inc较为活跃，换手率分别为5610.92%、1408.74%、141.93%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Azitra Inc、Transcode Therapeutics, Inc.，振幅分别为103.49%、42.43%、39.93%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206235326987c9c2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206235326987c9c2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0},{"id":"2509822472","title":"Tc Biopharm (Holdings) Plc盘中异动 股价大跌7.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509822472","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509822472?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:38","pubTimestamp":1738766308,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时38分，Tc Biopharm  Plc股票出现异动，股价大幅下挫7.56%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为1.14%。其相关个股中，Oragenics Inc.、Pasithea Therapeutics Corp.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Pasithea Therapeutics Corp.、Oragenics Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为3193.84%、825.71%、634.95%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Oragenics Inc.、Pasithea Therapeutics Corp.，振幅分别为54.05%、34.67%、27.88%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223828987b7d1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223828987b7d1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTTA","TCBP","BK4139"],"gpt_icon":0},{"id":"2509002466","title":"Tc Biopharm (Holdings) Plc盘中异动 大幅拉升5.26%报0.332美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509002466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509002466?lang=zh_cn&edition=full","pubTime":"2025-02-05 00:16","pubTimestamp":1738685817,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日00时16分，Tc Biopharm  Plc股票出现波动，股价快速上涨5.26%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为1.35%。其相关个股中，Azitra Inc、Estrella Immunopharma Inc C/Wts 29/09/2028、Evaxion Biotech As涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1632.71%、925.83%、469.73%，振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Quoin Pharmaceuticals Ltd，振幅分别为72.82%、49.88%、47.29%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205001658a2393d55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205001658a2393d55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCBP"],"gpt_icon":0},{"id":"2508014138","title":"Tc Biopharm (Holdings) Plc盘中异动 大幅下挫12.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508014138","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508014138?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:31","pubTimestamp":1738593099,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时31分，Tc Biopharm  Plc股票出现异动，股价大幅跳水12.72%。Tc Biopharm  Plc股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为312.39%、200.61%、126.16%，振幅较大的相关个股有Tc Biopharm  Plc、Briacell Therapeutics Corp.、Biocardia, Inc.，振幅分别为11.75%、6.97%、6.48%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223139a2380920&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223139a2380920&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCBP"],"gpt_icon":0},{"id":"2507966641","title":"Tc Biopharm (Holdings) Plc盘中异动 早盘快速下跌6.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507966641","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507966641?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:35","pubTimestamp":1738334143,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时35分，Tc Biopharm  Plc股票出现异动，股价快速下挫6.39%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.49%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312235439614eb56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312235439614eb56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TCBP"],"gpt_icon":0},{"id":"2507672716","title":"Tc Biopharm (Holdings) Plc盘中异动 下午盘股价大涨9.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507672716","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507672716?lang=zh_cn&edition=full","pubTime":"2025-01-31 03:11","pubTimestamp":1738264306,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日03时11分，Tc Biopharm  Plc股票出现波动，股价快速上涨9.00%。Tc Biopharm  Plc股票所在的生物技术行业中，整体涨幅为0.32%。Tc Biopharm  Plc公司简介：TC BioPharm  PLC 是一家临床阶段的生物制药公司，专注于开发基于其专有的同种异体 gamma delta T细胞平台的新型免疫治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501310311479876cfd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501310311479876cfd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TCBP","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tcbiopharm.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.7059},{"period":"3month","weight":-0.9376},{"period":"6month","weight":-0.9939},{"period":"1year","weight":-0.9982},{"period":"ytd","weight":-0.9516}],"compareEarnings":[{"period":"1week","weight":0.0567},{"period":"1month","weight":-0.0446},{"period":"3month","weight":-0.0802},{"period":"6month","weight":-0.0787},{"period":"1year","weight":0.0308},{"period":"ytd","weight":-0.089}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"TC BioPharm (Holdings) plc.是一家于2021年10月25日根据苏格兰法律注册成立的公司。该公司是一家临床阶段的生物制药公司，专注于开发基于专有的同种异体伽玛德尔塔T（GD-T）细胞平台的新型免疫治疗产品。利用GD-Ts的先天能力，该公司得以开发一系列临床阶段的细胞疗法，旨在对抗癌症和病毒感染。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.20243},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.252338},{"month":3,"riseRate":0.5,"avgChangeRate":-0.221857},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.078542},{"month":5,"riseRate":0,"avgChangeRate":-0.336698},{"month":6,"riseRate":0,"avgChangeRate":-0.348963},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.039359},{"month":8,"riseRate":0,"avgChangeRate":-0.098609},{"month":9,"riseRate":0,"avgChangeRate":-0.144118},{"month":10,"riseRate":0,"avgChangeRate":-0.375054},{"month":11,"riseRate":0,"avgChangeRate":-0.393989},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.199925}],"exchange":"NASDAQ","name":"TC BioPharm","nameEN":"TC BioPharm"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.0","shortVersion":"4.33.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TC BioPharm(TCBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TC BioPharm(TCBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TC BioPharm,TCBP,TC BioPharm股票,TC BioPharm股票老虎,TC BioPharm股票老虎国际,TC BioPharm行情,TC BioPharm股票行情,TC BioPharm股价,TC BioPharm股市,TC BioPharm股票价格,TC BioPharm股票交易,TC BioPharm股票购买,TC BioPharm股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TC BioPharm(TCBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TC BioPharm(TCBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况